Evidence map›Paper›PMID 40223095›Full record

ArticleCell & bioscience2025

Dysregulated ac4C modification of mRNA in a mouse model of early-stage Alzheimer's disease.

Hao-Nan Ji, Hai-Qian Zhou, Jing-Bo Qie, Wen-Mei Lu, Hai-Tao Gao, Dan-Hong Wu

Abstract read
In one paragraph

Article in Cell & bioscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hao-Nan Ji *Department of Neurology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, 200240, China.
Hai-Qian Zhou *Department of Neurology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, 200240, China.
Jing-Bo QieShanghai Fifth People's Hospital, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
Wen-Mei LuDepartment of Neurology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, 200240, China.
Hai-Tao GaoDepartment of Neurology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, 200240, China.
Dan-Hong WuDepartment of Neurology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, 200240, China. danhongwu@fudan.edu.cn.ORCID http://orcid.org/0000-0002-1132-6669

Funding

Scientific Research Project funded by Shanghai Fifth People's Hospital, Fudan University No. 2023WYZD02Shanghai Minhang District Health and Family Planning Commission (great discipline of Shanghai Minhang District 2024MWDXK04the Proton Cluster Incubation Project of the National Natural Science Foundation of China Grant No. 2025GZRFY01the Shanghai Committee of Science and Technology Grant No.23JC1401800 and No.23JC1401803
6 · The paper itself

Abstract

backgroundThe identification and intervention of Alzheimer's Disease (AD) in its early-stage allows for the timely implementation of lifestyle modifications and therapeutic strategies. Although dysregulation of protein expression has been reported in the brain from AD patients and AD animal models, the underlying mechanisms remain poorly understood. N4-acetylcytidine (ac4C), the only known form of RNA acetylation in eukaryotes, has recently been shown to regulate mRNA stability and translation efficiency. However, the dysregulation of ac4C associated with abnormal protein expression levels in the brain of early-stage mouse models of AD remains to be elucidated.

methodsThis study investigated ac4C modifications, mRNA and protein expression in the hippocampus of 3 and 6-month-old 5×FAD mice, a mouse model of AD, and wild-type (WT) littermates. The multi-omics analysis was performed: acetylated RNA immunoprecipitation followed by next-generation sequencing (acRIP-seq) to identify ac4C mRNAs, deep RNA sequencing (RNA-seq) to quantify mRNA abundance, and label-free quantitative proteomics to assess protein expression levels. In addition, we used acRIP-qPCR, regular qPCR and western blots to verify the ac4C, mRNA and protein levels of some key genes that were identified by the high-throughput assays.

resultsProteomic analysis revealed significant change of protein expression in the hippocampus of 3-months-old 5×FAD mice, compared with WT littermates. In contrast, RNA-seq analysis indicated that there were no substantial alterations in mRNA expression levels in the hippocampus of 3-months-old 5×FAD mice, compared to WT littermates. Strikingly, acRIP-seq revealed notable variations in ac4C modification on mRNAs, particularly those associated with synaptic structure and function, in the hippocampus of 3-months-old 5×FAD mice, compared with WT littermates. The ac4C modifications were found to be correlated with protein expression changes. Genes that are essential for synaptic function and cognition, including GRIN1, MAP2, and DNAJC6, exhibited reduced ac4C and protein levels in 3-months-old 5×FAD mice, without any corresponding changes in the mRNA levels, compared with WT littermates. Moreover, only a small part of dysregulated ac4C mRNAs identified in the 3-month-old 5×FAD mice were found in the 6-month-old 5×FAD mice.

conclusionsAltogether these results identified abnormal ac4C modification of mRNAs that may contribute to the dysregulation of protein synthesis in the hippocampus from an early-stage mouse model of AD.

Indexed as

ac4CAlzheimer’s diseaseGene transcriptionHippocampusProteomics

Identifiers

PMID40223095
PMCPMC11995559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.